These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3929851)

  • 21. Transmucosal controlled-release nitroglycerin.
    Med Lett Drugs Ther; 1987 Apr; 29(737):39-40. PubMed ID: 3104737
    [No Abstract]   [Full Text] [Related]  

  • 22. [Local treatment of anal fissure with nitroglycerin ointment].
    Osterwald-Lenum NS; Rosenberg J; Bülow S
    Ugeskr Laeger; 1998 Aug; 160(36):5211-4. PubMed ID: 9741288
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of skin-flap survival using nitroglycerin ointment.
    Rohrich RJ; Cherry GW; Spira M
    Plast Reconstr Surg; 1984 Jun; 73(6):943-8. PubMed ID: 6427801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure (Br J Surg 2007; 94: 162-167).
    Kelly T; Ballal M; Khera G
    Br J Surg; 2007 May; 94(5):646; author reply 646-7. PubMed ID: 17443857
    [No Abstract]   [Full Text] [Related]  

  • 25. Postoperative hypotension from topical use of 2% nitroglycerin ointment after a total knee replacement procedure.
    Siddiqi M; Marco AP; Gorp CV
    J Clin Anesth; 2004 Feb; 16(1):77-8. PubMed ID: 14984866
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusion due to phlebitis and extravasation.
    Wright A; Hecker JF; Lewis GB
    Lancet; 1985 Nov; 2(8465):1148-50. PubMed ID: 2865615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacodynamics of a nitroglycerin ointment in patients with stenocardia of effort].
    Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
    Kardiologiia; 1985 Apr; 25(4):41-4. PubMed ID: 3927053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application site for nitroglycerin ointment.
    Hansen MS
    Am J Cardiol; 1978 Dec; 42(6):1061. PubMed ID: 103418
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous administration of nitroglycerin: a review.
    Olivari MT; Cohn JN
    Pharmacotherapy; 1983; 3(3):149-57. PubMed ID: 6410359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.
    Qiao GL; Williams PL; Riviere JE
    Drug Metab Dispos; 1994; 22(3):459-71. PubMed ID: 8070325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic effects of per os and percutaneous administration of nitroglycerin in severe cardiac insufficiency. Comparative study with intravenous nitroglycerin].
    Metzger JP; Zannier-Marzari D; Montgermont P; N'Koua JL; Baubion N; Le Pailleur C; Vacheron A
    Therapie; 1985; 40(3):173-6. PubMed ID: 3925587
    [No Abstract]   [Full Text] [Related]  

  • 35. [The kinetics of in vitro release of nitroglycerin from various percutaneous administration systems].
    Pirotte B; Jaminet F
    J Pharm Belg; 1984; 39(3):125-35. PubMed ID: 6434726
    [No Abstract]   [Full Text] [Related]  

  • 36. New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
    Abrams J
    Z Kardiol; 1985; 74 Suppl 4():10-5. PubMed ID: 3938113
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation.
    Griffith P; James B; Cropp A
    Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system.
    Karim A
    Angiology; 1983 Jan; 34(1):11-22. PubMed ID: 6401951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.